90 Startups
  • Sector
  • Participated in
  • Year of participation

Oncodrone

  • 2009
  • Other
  • Therapeutics
Precision medicines for cancer

PacingCure

  • 2020
  • Therapeutics
  • Venture Challenge
PacingCure develops gene therapies for common cardiac arrhythmias and cardiomyopathies

Panorama Laboratories

  • 2020
  • Enabling Technology
  • Venture Challenge
Panorama Laboratories is building a new class of lab devices. Instead of measuring characteristics of samples, we measure characteristics of protocols while they are being executed. These devices will allow for instant and objective documentation of high impact actions in the lab.

Praxa Sense

  • 2019
  • Diagnostics
  • Venture Challenge
Easy & accurate long-term monitoring for Atrial Fibrillation. By providing unobtrusive, long-term monitoring and reliable diagnosis, Praxa Sense offers a solution to detect heart rhythm diseases in an early stage, preventing up to 9 strokes each day in The Netherlands alone.

Precision Immunomics

  • 2018
  • Diagnostics
  • Venture Challenge
We developed a test that accurately identifies patients that will develop rheumatoid arthritis within 3 years. Our mission is to substantially reduce the high burden of this disease by helping rheumatologists worldwide identify these high-risk patients in order to start preventive therapy.

Predica Diagnostics

  • 2018
  • Diagnostics
  • Venture Challenge
Predica’s mission is to personalize the population based screening program cervical cancer and thereby prevent overdiagnosis and unnecessary treatment of healthy women who test positive in the current screening program.

Prolira

  • 2014
  • Diagnostics
  • Value Centre
  • Venture Challenge
Prolira provides the first proprietary and validated biomarker-based medical device to detect the onset of delirium, with a sensitivity of 90%. This enables health care professionals in realising better patient outcome, saving hospital days and reducing costs.

Protinhi

  • 2012
  • Other
  • Therapeutics
  • Venture Challenge
Combating viral infectious diseases with a high unmet medical need. Treating disease via protease inhibition.

Quirem Medical

  • 2012
  • 2016
  • Other
  • Therapeutics
  • Value Centre
Quirem Medical is an emerging medical device company with a mission to develop and commercialize the next generation microspheres for targeted interventional treatment of liver malignancies.

QVQ

  • 2011
  • Enabling Technology
  • Other
Labelled single domain antibodies from camelids (professionally called functionalized VHH) for Research and Imaging.